15-49371337-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152647.3(FAM227B):āc.1075A>Gā(p.Lys359Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000355 in 1,603,650 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152647.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM227B | NM_152647.3 | c.1075A>G | p.Lys359Glu | missense_variant | 12/16 | ENST00000299338.11 | NP_689860.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM227B | ENST00000299338.11 | c.1075A>G | p.Lys359Glu | missense_variant | 12/16 | 2 | NM_152647.3 | ENSP00000299338 | P1 | |
FAM227B | ENST00000559573.3 | n.385A>G | non_coding_transcript_exon_variant | 3/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000444 AC: 11AN: 247748Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134154
GnomAD4 exome AF: 0.0000372 AC: 54AN: 1451352Hom.: 0 Cov.: 26 AF XY: 0.0000374 AC XY: 27AN XY: 722490
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152298Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2024 | The c.1075A>G (p.K359E) alteration is located in exon 12 (coding exon 11) of the FAM227B gene. This alteration results from a A to G substitution at nucleotide position 1075, causing the lysine (K) at amino acid position 359 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at